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OBJECTIVE To assess the relationship between dysglycemia and myocardial infarction in nondiabetic
individuals.
BACKGROUND Nondiabetic hyperglycemia may be an important cardiac risk factor. The relationship between
myocardial infarction and glucose, insulin, abdominal obesity, lipids and hypertension was
therefore studied in South Asians—a group at high risk for coronary heart disease and
diabetes.
METHODS Demographics, waist/hip ratio, fasting blood glucose (FBG), insulin, lipids and glucose
tolerance were measured in 300 consecutive patients with a first myocardial infarction and 300
matched controls.
RESULTS Cases were more likely to have diabetes (OR 5.49; 95% CI 3.34, 9.01), impaired glucose
tolerance (OR 4.08; 95% CI 2.31, 7.20) or impaired fasting glucose (OR 3.22; 95% CI 1.51,
6.85) than controls. Cases were 3.4 (95% CI 1.9, 5.8) and 6.0 (95% CI 3.3, 10.9) times more
likely to have an FBG in the third and fourth quartile (5.2–6.3 and .6.3 mmol/l); after
removing subjects with diabetes, impaired glucose tolerance and impaired fasting glucose,
cases were 2.7 times (95% CI 1.5–4.8) more likely to have an FBG .5.2 mmol/l. A fasting
glucose of 4.9 mmol/l best distinguished cases from controls (OR 3.42; 95% CI 2.42, 4.83).
Glucose, abdominal obesity, lipids, hypertension and smoking were independent multivariate
risk factors for myocardial infarction. In subjects without glucose intolerance, a 1.2 mmol/l
(21 mg/dl) increase in postprandial glucose was independently associated with an increase in
the odds of a myocardial infarction of 1.58 (95% CI 1.18, 2.12).
CONCLUSIONS A moderately elevated glucose level is a continuous risk factor for MI in nondiabetic South
Asians with either normal or impaired glucose tolerance. (J Am Coll Cardiol 1999;33:612–9)
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Diabetes mellitus and hypercholesterolemia are well estab-
lished risk factors for coronary artery disease (CAD). Patients
with CAD also have a high rate of glucose intolerance,
hypertriglyceridemia, low high density lipoprotein (HDL)
levels, insulin resistance and hyperinsulinemia, in addition to
abdominal obesity and hypertension. The observation that
different ethnic groups have different rates of CAD suggests
that these groups may differ with respect to the frequency or
nature of predisposing metabolic risk factors, and/or with
respect to their susceptibility to these risk factors.
South Asians constitute one sixth of humanity and
experience much higher rates of coronary heart disease than
other ethnic groups in the world (1–6). The World Bank
estimates that the death rate from coronary heart disease
will increase dramatically in the Indian subcontinent and is
expected to contribute to more quality-adjusted life years lost
over the next 20 years than in any other part of the world (7).
South Asians also have up to a five-fold (8,9) higher rate
of type 2 diabetes mellitus, as well as a higher rate of glucose
intolerance, low HDL, high triglycerides and abdominal
obesity than people of European ancestry. Despite the high
prevalence of both CAD and metabolic risk factors for CAD
in the South Asian Indian population, there are sparse data
linking the two in these populations. This article reports the
relationship between myocardial infarction and body fat dis-
tribution, hypertension, glucose tolerance status, glucose, insu-
lin and lipid levels in a case-control study completed in India.
METHODS
Subjects. Details of the design of this hospital-based case-
control study have been reported previously (10). This
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article reports an extension of the previous report of 400
subjects to 600 subjects (300 cases and 300 controls) and
focuses on the role of diabetes and abnormalities in glucose
tolerance, as defined by the recently revised diagnostic
criteria for the classification of diabetes (11). Cases were
defined as consecutive patients between the ages of 30 and
60 years (inclusive) who were admitted to the coronary care
unit of the hospital with a first acute MI. The diagnosis of
acute MI required a history of typical chest pain lasting at
least 20 min, a standard 12 lead electrocardiogram (ECG)
showing ST elevation of 2 mm or more in two or more
contiguous leads and subsequent evolution of cardiac en-
zymes. Controls were selected from outpatients attending
the hospital clinic for refraction, otorhinolaryngology eval-
uation or a general physical examination or from inpatients
admitted for cataract extraction or herniorrhaphy. Both
cases and controls were excluded if they had any previous
diagnosis of heart disease, clinical evidence of liver disease
(jaundice, ascites or prominent abdominal veins), or a
history of dietary modification in the month prior to
admission. They were also excluded if a fasting blood
sample could not be drawn within 24 h of the onset of chest
pain because the effect of acute MI on lipid levels occurs
after this period (12). Controls were also excluded if their 12
lead ECG showed pathological Q waves, ST segment
deviation, T wave inversion, bundle branch or atrioventric-
ular block, tachyarrhythmia (other than isolated atrial ec-
topic beats) or chamber hypertrophy. Controls were
matched to cases for age (within 5 years) and gender. A
subject was classified as having diabetes if they reported a
history of diabetes, or if the fasting blood glucose (FBG) or
postprandial blood glucose (PPBG) was $7.0 mmol/l
(126 mg/dl) or $11.1 mmol/l (200 mg/dl) respectively (11).
A subject was classified as having impaired glucose tolerance
(IGT) if the PPBG was $7.78 mmol/l (140 mg/dl) and
,11.1 mmol/l (200 mg/dl) and the FBG was ,7.0 mmol/l
(126 mg/dl); impaired fasting glucose (IFG) was diagnosed
if the FBG was $6.1 mmol/l (110 mg/dl) and ,7.0 mmol/l
(126 mg/dl). Subjects without known diabetes who did not
have a glucose tolerance test were classified on the basis of
their fasting glucose alone.
Variables measured. Age, gender, religion, monthly in-
come, educational level, dietary details, smoking habits,
alcohol use and a history of diabetes mellitus and hyperten-
sion were recorded for all subjects. Weight, height, and
waist and hip circumference were determined for each
subject; waist circumference was measured at the narrowest
diameter between the costal margin and the iliac crest, and
hip circumference was measured at the greatest diameter
over the glutei.
Fasting total cholesterol, HDL cholesterol, low density
lipoprotein (LDL) cholesterol, and total triglyceride were
measured within 24 hours of the onset of chest pain for
cases and prior to any surgery for controls. Fasting blood
glucose in plasma was measured on the 9th or 10th day after
admission for cases and at the time of lipid measurement for
controls. In addition those subjects without a previous
history of diabetes had blood drawn for fasting insulin levels
at this time; they then had a PPBG measured two hours
after drinking 75 grams of glucose. Patients were not on any
intravenous therapy when glucose levels were measured.
Total cholesterol and triglycerides were estimated by
enzymatic methods (cholesterol oxidase/peroxidase-
aminophenazone for cholesterol, glycerol phosphate
oxidase/peroxidase-aminophenazone for triglycerides) on an
automated system using standard kits (Boehringer Mann-
heim Gmbh). High density lipoprotein cholesterol was
estimated using a precipitation method and LDL choles-
terol was calculated (total cholesterol-HDL cholesterol-
triglycerides/5). Glucose was assayed by the glucose oxidase
method and serum insulin was estimated by radioimmuno-
assay (kit manufactured by the Board of Radiation and
Isotope Technology, Bombay). All biochemical analyses
were conducted without knowledge of the clinical informa-
tion.
Statistical methods. For the analyses in which all cases
were compared to all controls, cases were matched with the
next control subject recruited and estimates of odds ratios
(ORs) and 95% confidence intervals were based on analyses
of matched-pair data. Unmatched analyses were used to
compare nondiabetic or diabetic cases to nondiabetic or
diabetic controls because cases were not matched to controls
on the basis of diabetes status. Because of the skewed
distribution of continuous variables, nonparametric univar-
iate analyses were used. Univariate comparisons of frequen-
cies were done using chi square tests.
For multivariate model building, all nonnormal variables
were transformed and stepwise multiple logistic regression
analyses were performed to identify the best independent
determinants of myocardial infarction (MI). Case-control
matching was used for analyses of all cases and controls. For
nondiabetic and non-IGT subgroups, an unmatched model
was used with age and sex added as covariates. Based on
these logistic regression models, cutpoints for the receiver
operating curve (ROC) analyses were those that optimized
the cross-product ratio.
Abbreviations and Acronyms
CAD 5 coronary artery disease
ECG 5 electrocardiogram
FBG 5 fasting blood glucose
HDL 5 high density lipoprotein
IFG 5 impaired fasting glucose
IGT 5 impaired glucose tolerance
LDL 5 low density lipoprotein
MI 5 myocardial infarction
OR 5 odds ratio
PPBG 5 postprandial blood glucose
ROC 5 receiver operating curve
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The following variables were included in all of the
multivariate analyses: fasting glucose, postprandial glucose
(in nondiabetic subjects), waist/hip ratio, cholesterol, tri-
glycerides, HDL cholesterol, LDL cholesterol, cholesterol/
HDL and smoking status. In addition, diabetes status
(yes/no) was entered in the regression analysis of all cases
and controls; IGT status (yes/no), postprandial glucose and
insulin level in the regression analysis of nondiabetic cases
and controls; and impaired fasting glucose status (yes/no),
postprandial glucose and insulin levels in the regression
analysis of non-IGT cases and controls. BMDP LR (step-
wise logistic regression) with a p-value for entry of a variable
into the model of p 5 0.10 and p 5 0.15 to remove variables
was used for this analysis.
Figures illustrating the unadjusted relationship between
glucose values and odds ratios for all subjects and for
nondiabetic subjects were constructed from univariate logis-
tic regression coefficients. The SAS and BMDP statistical
packages were used for all statistical analyses. p values are
two-tailed.
RESULTS
Table 1 describes the clinical and biochemical characteristics
of the 300 cases and 300 controls. Overall, there was a
higher prevalence of previously diagnosed diabetes and
hypertension in cases. Moreover, cases had a higher waist/
hip ratio (p 5 0.0001), higher FBG (p 5 0.0001) and
PPBG (p 5 0.0001) and higher fasting insulin (p 5 0.003).
There was no difference in either body mass index or lipid
values.
Diabetes and impaired glucose tolerance. A history of
diabetes was obtained in 87 subjects (61 cases, 26 controls)
at the time of presentation. No glucose levels were recorded
in 6 subjects (4 cases, 2 controls) no PPBG levels were
recorded in 59 subjects (43 cases, 16 controls) and no FBG
was recorded in 1 case who was classified with diabetes on
the basis of a PPBG of 11.7 mmol/l. On the basis of their
recorded glucose levels, 66 subjects (49 cases, 17 controls)
were diagnosed with diabetes, 82 subjects (54 cases, 28
controls) were classified as having impaired glucose toler-
ance and 41 subjects (25 cases, 16 controls) were classified as
having impaired fasting glucose (IFG). Therefore, a total of
189 cases (63.9%) and 87 controls (29.2%) had either
diabetes, impaired glucose tolerance or IFG. The distribu-
tion and odds ratios for each of these diagnoses is listed in
Table 2.
The results for subjects with and without diabetes were
analyzed separately to explore the relationship between
nondiabetic levels of glycemia and myocardial infarction.
Both diabetic and nondiabetic cases had a higher waist/hip
ratio than controls (p 5 0.05 and p 5 0.0001, respectively).
Nondiabetic cases also had higher FBG and PPBG levels
Table 1. Characteristics of Myocardial Infarction Cases and Controls
Cases
N 5 300†
Controls
N 5 300 p Value*
Age 47.2 (7.9) 46.8 (7.8) Matched
Males (%) 279 (93%) 279 (93%) Matched
Reported diabetes history 61 (20.3%) 26 (8.7%) 0.0001
History of hypertension 51 (17.0%) 24 (8.0%) 0.0009
Body mass index 22.8 (3.3) 22.8 (4.0) 0.62
Waist/hip ratio 0.93 (0.06) 0.89 (0.06) 0.0001
Fasting insulin (pmol/l) 149.9 (127.7) 137.0 (180.1) 0.003
[N 5 187] [N 5 240]
Fasting glucose (mmol/l) 6.79 (3.2) 5.43 (2.1) 0.0001
[N 5 295] [N 5 298]
Postprandial glucose (mmol/l) 8.36 (3.3) 6.84 (3.4) 0.0001
[N 5 196] [N 5 259]
Total cholesterol (mmol/l) 4.88 (1.19) 4.74 (0.99) 0.47
[N 5 298] [N 5 298]
Triglycerides (mmol/l) 2.14 (1.55) 1.88 (1.03) 0.24
[N 5 298] [N 5 297]
HDL cholesterol (mmol/l) 1.15 (0.26) 1.16 (0.27) 0.81
[N 5 297] [N 5 298]
LDL cholesterol (mmol/l) 2.78 (0.99) 2.74 (0.87) 0.91
[N 5 278] [N 5 287]
Cholesterol/HDL ratio 4.35 (1.32) 4.24 (1.16) 0.32
[N 5 297] [N 5 298]
*Chi square and Wilcoxon rank sum tests were used for discrete and continuous variables; continuous variables are reported as
means (standard deviation). †Data based on N 5 300 unless noted in square brackets.
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than nondiabetic controls (p 5 0.0001 for both); fasting
insulin levels (available in 150 nondiabetic cases and
218 nondiabetic controls) were marginally lower in cases
(133.4 pmol/l and 134.1 pmol/l for cases and controls,
respectively; p 5 0.03).
Continuous relationship between glucose and risk of
myocardial infarction. The odds ratios for MI in all
subjects increased with increasing FBG quartiles (Fig. 1)
and was greater than 1 at FBG levels clearly below the
nondiabetic and impaired glucose tolerance range. For
example, cases were 3.4 times (95% CI 1.9–5.8) more likely
to have an FBG between 5.2 mmol/l (94 mg/dl) and
6.3 mmol/l (114 mg/dl) than controls. This continuous
relationship was maintained in the analysis of nondiabetic
subjects and was also clearly maintained after removing all
subjects with diabetes, IGT and IFG (Fig. 1D). Compared
to subjects with an FBG #4.5 mmol/l (81 mg/dl), the odds
Figure 1. Fasting glucose quartiles and the risk of myocardial infarction in all subjects. The odds of a myocardial infarction increase with
glucose quartile (A) even after subjects with diabetes are excluded (B), subjects with both diabetes and impaired glucose tolerance are
excluded (C) and subjects with diabetes, impaired glucose tolerance and impaired fasting glucose are excluded (D). (D) only includes
subjects whose fasting glucose is ,6.1 mmol/l (i.e., those with no IFG). The actual odds ratios and 95% confidence intervals are above
the bars.
Table 2. Glucose Tolerance Status of Cases and Controls
N
Cases
(%)
Controls
(%)
Odds Ratios
(95% CI)*
Diabetes 153† 110 (37.2) 43 (14.4) 5.49 (3.34, 9.01)
Impaired Glucose Tolerance 82 54 (18.2) 28 (9.4) 4.08 (2.31, 7.20)
Impaired Fasting Glucose 41 25 (8.4) 16 (5.4) 3.22 (1.51, 6.85)
Normal Glucose Tolerance 318 107 (36.2) 211 (70.8) 1
Total 594 296 298 N/A
*These odds ratios and 95% confidence intervals were derived from a logistic regression of the matched cases and controls; p ,
0.0001. †This category includes subjects with an established diagnosis of diabetes as well as subjects with a fasting glucose
$7.0 mmol/l (126 mg/dl) or a postprandial glucose $11.1 mmol/l (200 mg/dl).
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ratio for MI in subjects in this latter group with an FBG of
5.2 to 6.3 mmol/l (94 to 114 mg/dl) was 2.7 (95% CI
1.5–4.8).
Receiver operating curve analysis: distinguishing cases
from controls. To further explore the observed relationship
between FBG, PPBG, insulin levels and CAD, and to
determine the extent to which these biochemical markers
discriminated between cases and controls, the distributions
of these values were plotted (Fig. 2) and subjected to ROC
analysis (Table 3). An FBG of 4.9 mmol/l (89 mg/dl) best
differentiated all cases from controls. Seventy percent of
cases had an FBG $4.9 mmol/l (89 mg/dl); these patients
were 3.42 times more likely to be a case than a control (95%
CI 2.42–4.83). Similar analyses for the postprandial glucose
level yielded a cutpoint of 6.8 mmol/l (123 mg/dl; OR 5
3.84; 95% CI 2.59–5.67). When the analysis was restricted
to nondiabetic patients, similar fasting and postprandial
glucose cutpoints of 5.1 mmol/l (91 mg/dl) and 7.1 mmol/l
(128 mg/dl) were obtained (Table 3). A waist/hip ratio
$0.89 best differentiated all cases from controls (OR 5
3.24; 95% CI 5 2.24–4.69; 81% of cases’ waist/hip ratios
were $0.89). No fasting insulin level clearly separated cases
from controls.
Multiple logistic regression. A matched multiple logistic
regression analysis that included the variables (transformed
for normality where appropriate) measured in all subjects
(i.e., diabetes status, history of hypertension, inverse of
FBG, waist/hip ratio, lipid levels, smoking status and
presence or absence of diabetes or IGT) was done to identify
the independent determinants of myocardial infarction.
Current smoking (p , 0.001), waist/hip ratio (p , 0.001),
total cholesterol/HDL cholesterol ratio (p 5 0.01) and
presence or absence of diabetes (p , 0.001) or hypertension
(p 5 0.02) independently differentiated cases from controls.
Figure 2. Distribution of cases and controls according to glucose and insulin levels. The frequency distribution of fasting glucose levels
(a) in all cases and controls, and of fasting glucose (b), postprandial glucose (c) and fasting insulin (d) in nondiabetic cases and controls
is shown. Values that best discriminated cases from controls were calculated in an ROC analysis (Table 3) and are indicated by the dotted
lines.
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Because PPBG was not measured in the diabetic subjects,
this variable was not included in this analysis. Similar
findings were noted when the analysis was restricted to
nondiabetic subjects and subjects without impaired glucose
tolerance, in whom both FBG and PPBG as well as fasting
insulin levels were measured and entered into the regression
in addition to all of the other variables listed above. Insulin
levels were not independent variables in any model tested.
Table 4 lists the odds ratios for an increase in 1 standard
deviation of the variables included in the regression models
for all subjects, nondiabetic subjects and non-IGT subjects.
After adjustment for smoking status, waist/hip ratio and
triglyceride level, an increase in PPBG of 1.2 mmol/l or
21 mg/dl (1 standard deviation) increased the odds of an MI
1.58 times (95% CI 1.18, 2.12) in non-IGT subjects.
DISCUSSION
This case control study clearly shows that a high fasting or
postprandial glucose level, as well as a high waist/hip ratio
and history of hypertension and current smoking are inde-
pendently associated with the risk of myocardial infarction
in South Asians. It also shows that fasting (4.9 mmol/l or
89 mg/dl) or postprandial (6.8 mmol/l or 123 mg/dl)
glucose levels lower than those associated with diabetes,
IGT or even impaired fasting glucose clearly differentiate
MI cases from controls and that the risk of MI increases
progressively as the glucose levels increase from normal right
into the diabetic range. Thus glucose elevation above a
relatively low dysglycemic threshold (13) appears to be a
continuous risk factor for cardiovascular disease in this
population.
Glucose levels and cardiovascular risk. These results are
consistent with data from other populations suggesting a
progressive relationship between glucose levels and an in-
creased risk of cardiovascular disease in both nondiabetic
(14–17) and diabetic patients (18–21). They are also
consistent with a metaregression analysis of all cohort
studies of nondiabetic patients in which baseline glucose
levels were related to subsequent cardiovascular events and
mortality (22). The observation that the glucose-associated
risk persisted even after controlling for other risk factors
suggests that glucose elevation is an independent marker for
atherosclerosis in South Asians.
Table 3. Values That Best Discriminated Myocardial Infarction Cases from Controls
Overall* Nondiabetic Subjects
Cutpoint†
Odds Ratio
(95% CI) Cutpoint†
Odds Ratio
(95% CI)
Fasting glucose (mmol/l) 4.9 3.42 (2.42, 4.83) 5.1 3.12 (2.10, 4.63)
Postprandial glucose (mmol/l) 6.8§ 3.84 (2.59, 5.67) 7.1 4.23 (2.72, 6.58)
Fasting insulin None‡ N/A None‡ N/A
Waist/hip ratio 0.89 3.24 (2.24, 4.69) 0.93 2.93 (1.96, 4.37)
*The overall analysis was based on the matched analysis in which one case was matched to one control; the diabetic and
nondiabetic analyses were done on unmatched data (because patients were not matched on the basis of diabetes status during the
study). †Cutpoints are the levels which best separate cases from controls based on a receiver operating curve analysis. ‡No clear
cutpoint was apparent from the analysis. §Glucose tolerance tests and insulin levels were not done in patients with known
diabetes.
Table 4. Multivariate Odds Ratios for the Independent Determinants of Myocardial Infarction
Independent Variable*
All Subjects
Model†
Nondiabetic
Subjects
Model
Non-IGT
Subjects
Model
Diabetes status 4.89 (2.66, 9.00) N/A N/A
Postprandial glucose‡ N/A 2.01 (1.56, 2.59) 1.58 (1.18, 2.12)
Waist/hip ratio 2.41 (1.75, 3.31) 1.58 (1.19, 2.10) 1.79 (1.29, 2.48)
Cholesterol/HDL ratio 1.36 (1.06, 1.75) not in model not in model
Triglyceride not in model 0.73 (0.61, 0.88) 0.72 (0.52, 1.00)
Hypertension 2.52 (1.13, 11.4) 4.91 (1.86, 12.9) not in model
Smoking 6.52 (3.71, 11.4) 7.77 (4.24, 14.2) 5.98 (2.94, 12.2)
*Whether or not a continuous variable was an independent predictor was determined on the basis of its continuous distribution.
In this table, however, the increase in odds for every 1 standard deviation (SD) increase in the value of the independent
continuous variables are reported. For the model that included all subjects, 1 SD for the waist/hip ratio 5 0.06 and for the total
cholesterol/HDL cholesterol ratio 5 1.13; for the model that only included nondiabetic subjects, 1 SD for PPBG 5 2.3 mmol/l
(41 mg/dl), for waist/hip ratio 5 0.06 and for triglycerides 5 1.09 mmol (94 mg/dl); for the model that only included non-IGT
subjects, 1 SD for PPBG 5 1.2 mmol/l (21 mg/dl), waist/hip ratio 5 0.06 and triglycerides 5 1.11 mmol/l (96.7 mg/dl). †A
matched logistic regression analysis was done for all subjects, and an unmatched analysis (not matched on diabetes status but
adjusted for age and sex) was done for nondiabetic and nonimpaired glucose tolerance (non-IGT) subjects. ‡Postprandial glucose
was not measured in diabetic subjects.
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Lipid and insulin levels and cardiovascular risk. The fact
that the cholesterol/HDL ratio was an independent deter-
minant of MI in the multivariate analysis of all subjects and
the fact that triglyceride levels were not an independent
determinant of MI is consistent with other epidemiologic
studies (23,24). The fact that this ratio was not an indepen-
dent determinant of MI in the nondiabetic subjects may
have been due to the lower power to detect such a
relationship in this smaller subgroup. In the univariate
analysis of the nondiabetic subgroup, triglyceride levels were
nonsignificantly higher in cases than in controls (data not
shown). After adjustment for other risk factors, however,
there was an inverse correlation in this subgroup. This may
have been due to the fact that some of the MI case subjects
were treated with intravenous heparin—a therapy known to
lower triglyceride levels (25).
The observation that insulin levels were not independent
risk factors for MI in the logistic regression suggests that the
moderately higher insulin levels observed in cases may have
occurred in response to the elevated glucose levels (26,27). It
is also consistent with epidemiologic data from other
populations suggesting that hyperinsulinemia alone may not
be a strong determinant of cardiovascular disease (28). The
possibility that the preinfarct hyperinsulinemia may have
been minimized in post-MI cases (at the time of insulin
sampling), however, cannot be ruled out.
Waist/hip ratio and cardiovascular risk. The waist/hip
ratio strongly discriminated cases from controls and was a
strong independent risk factor for MI in this population.
Conversely, body mass index had no discriminative value.
Evidence that a high waist/hip ratio reflects visceral fat
accumulation, and that visceral fat is associated with abnor-
malities in glucose and fatty acid metabolism suggest that it
is a surrogate measure for an atherogenic metabolic state
(29–31). Moreover, the independence of the high waist/hip
ratio in the logistic regression suggests that this ratio reflects
metabolic abnormalities that are distinct from those related
to the higher glucose level. The nature of these abnormal-
ities is currently unknown.
Limitations of the case-control design. These data are
limited by the case-control design. First, only one glucose
tolerance test was done in cases and controls who did not
have a history of diabetes. Even under ideal circumstances
the postprandial (2 h) glucose result in this test is not highly
reproducible (32). As this variability may be even more
pronounced in patients who are within two weeks of a
myocardial infarction, the classification of cases into those
with diabetes and IGT according to postprandial glucose
values may not be robust. Second, the postprandial glucose
level is increased in people who are inactive or who are not
consuming a high carbohydrate diet for several days prior to
the test (33). It may also have been affected by drugs
prescribed in the post-MI period. This may have magnified
the elevation in postprandial glucose levels seen in nondia-
betic cases (in whom glucose tolerance tests was done 9 to
10 days after admission for myocardial infarction) compared
with nondiabetic controls (in whom glucose tolerance tests
were done within 24 h of admission) and may have
overestimated the number of cases who had (previously
undiagnosed) diabetes. Despite these possibilities, the de-
tection of clear and consistent differences in the distribution
of the FBG (which are more robust than the PPBG
[32,33]) as well as the PPBG among cases and controls
regardless of diagnosis (i.e., in all subjects and in those
without diabetes or IGT) strongly supports the inference
that dysglycemia is an important and independent cardiac
risk factor in this population.
Implications and conclusions. The finding of a graded
risk of MI with glucose elevations within the “normal” range
in South Asians strongly supports the need to explore this
relationship in other ethnic groups. If these observations are
confirmed, the population attributable risk of dysglycemia
(i.e., the excess risk of MI in the general population
attributable to glucose elevations above some low dysglyce-
mic threshold) may be several times greater than the
population attributable risk of diabetes alone. This would
focus attention on the high prevalence of elevated glucose
levels in the nondiabetic population and may lead to
innovative ways of preventing cardiovascular disease in this
group.
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